FrancophonIA/ELRC3.0 huggingface dataset:
English: You can carry your Ryzodeg pre-filled pen (FlexTouch) with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C to 8°C) for up to 4 weeks.
Croatian: Nakon prvog otvaranja ili ako se lijek nosi kao rezervni Ryzodeg napunjenu brizgalicu (FlexTouch) možete nositi sa sobom i čuvati na sobnoj temperaturi (ne iznad 30°C) ili u hladnjaku (2°C do 8°C) do 4 tjedna.
English: Headache; slurred speech; fast heartbeat; cold sweat, cool pale skin; feeling sick, feeling very hungry; tremor or feeling nervous or worried; feeling unusually tired, weak and sleepy; feeling confused, difficulty in concentrating; short-lasting changes in your sight.
Croatian: Upozoravajući znakovi preniske razine šećera u krvi - mogu nastupiti iznenada: glavobolja; otežani govor; ubrzani otkucaji srca; hladan znoj, hladna blijeda koža; mučnina, osjećaj jake gladi; drhtanje ili nervoza ili zabrinutost; osjećaj neuobičajenog umora, slabosti i pospanosti; osjećaj smetenosti, poteškoće s koncentracijom; kratkotrajne promjene vida.
English: After subcutaneous injection, soluble and stable multi-hexamers of insulin degludec are formed creating a depot of insulin in the subcutaneous tissue, while not interfering with the rapid release of insulin aspart monomers into the circulation.
Croatian: Apsorpcija Nakon supkutane injekcije, dolazi do stvaranja topivih i stabilnih multiheksamera degludek inzulina te nastaje depo inzulina u supkutanom tkivu, pri čemu nije ometen brzi ulazak monomera aspart inzulina u cirkulaciju.
English: EU/1/12/806/005 10 pens of 3 mL
Croatian: EU/1/12/806/005 10 brizgalica od 3 ml
English: Patients with type 2 diabetes mellitus Ryzodeg can be administered once or twice daily with the main meal(s) alone, in combination with oral antidiabetic medicinal products, and in combination with bolus insulin (see section 5.1).
Croatian: Ryzodeg se može primjenjivati jednom ili dva puta dnevno uz glavni obrok (glavne obroke) u monoterapiji, u kombinaciji s oralnim antidijabeticima te u kombinaciji s bolus inzulinom (vidjeti dio
English: Do not use this medicine after the expiry date which is stated on the Penfill label and carton, after ‘EXP'.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici Penfill uloška i na kutiji iza oznake ‘Rok valjanosti'.
English: At week 16, the mean total daily insulin dose was 0.88 vs 1.01 units/kg in the Ryzodeg and insulin detemir arms, respectively.
Croatian: Srednja vrijednost ukupne dnevne doze inzulina u 16. tjednu iznosila je 0,88 jedinica/kg u skupini koja je primala Ryzodeg naspram 1,01 jedinice/kg u skupini liječenoj detemir inzulinom.
English: In two trials combining insulin and OAD treatment in both insulin-naïve (insulin initiation) and insulin-using (insulin intensification) patients with type 2 diabetes mellitus, Ryzodeg o.d. demonstrated similar glycaemic control (HbA1c) compared to IGlar (administered according to label) (Table 1).
Croatian: U dva ispitivanja u kojima je kombinirano liječenje inzulinom i OAD u bolesnika sa šećernom bolešću tipa 2 koji nisu koristili inzulin (početak primjene inzulina) i koji su koristili inzulin (intenziviranje inzulinskog liječenja), Ryzodeg j.d. pokazao je sličnu regulaciju glikemije (HbA1c) u usporedbi s IGlar (primijenjen u skladu s odobrenjem) (Tablica 1).
English: When the pen is empty, throw it away without a needle on as instructed by your doctor, nurse, pharmacist or local authorities.
Croatian: Kad je brizgalica prazna, bacite je u otpad bez nataknute igle, sukladno uputama Vašeg liječnika,
English: Ryzodeg').
Croatian: u nastavku).
English: The pre-filled pen delivers 1-80 units in steps of 1 unit.
Croatian: Napunjena brizgalica isporučuje 1-80 jedinica u stupnjevima od 1 jedinice.
English: Difference: 0.23 [-0.46;0.91]
Croatian: Razlika: 0,23 [-0,46; 0,91]
English: IDet (o.d./b.i.d.
Croatian: IDet (j.d./d.d.)2
English: • if the cartridge or the delivery system you are using is damaged.
Croatian: • Ako su uložak ili pomagalo za primjenu inzulina oštećeni.
English: Ratio: 1.43 [1.07;1.92]
Croatian: Omjer: 1,43 [1,07; 1,92]
English: Insulin degludec monomers gradually separate from the multi-hexamers thus resulting in a slow and continuous delivery of insulin degludec into the circulation.
Croatian: Monomeri degludek inzulina postupno se odvajaju od multiheksamera, čime dolazi do sporog i neprestanog ulaska degludek inzulina u cirkulaciju.
English: Difference: 0.51 [0.09;0.93]
Croatian: Razlika: 0,51 [0,09; 0,93]
English: • Check the name and strength on the label to make sure it is Ryzodeg 100 units/mL.
Croatian: • Provjerite naziv i jačinu na naljepnici kako biste bili sigurni da je to Ryzodeg 100 jedinica/ml.
English: Ryzodeg is administered subcutaneously by injection in the abdominal wall, the upper arm or the thigh.
Croatian: Ryzodeg se primjenjuje supkutanom injekcijom u trbušnu stijenku, nadlakticu ili bedro.
English: There is no experience with the use of Ryzodeg in children below the age of 2 years.
Croatian: Nema iskustva s primjenom lijeka Ryzodeg u djece mlađe od 2 godine.
English: • Unscrew the needle and dispose of it carefully.
Croatian: • Odvijte iglu i pažljivo je bacite u otpad.
English: In one trial in type 2 diabetes mellitus Ryzodeg o.d. was compared to insulin glargine (IGlar) o.d. plus IAsp o.d. After 26 weeks of treatment the Ryzodeg dose could be split into b.i.d.
Croatian: U jednom ispitivanju kod šećerne bolesti tipa 2 Ryzodeg primijenjen jednom dnevno uspoređivao se s glargin inzulinom (IGlar) j.d. plus IAsp j.d. Nakon 26 tjedana liječenja doza lijeka Ryzodeg mogla se podijeliti na dvije (d.d.).
English: 70% insulin degludec / 30% insulin aspart
Croatian: 70% degludek inzulin / 30% aspart inzulin
English: Patients switching from more than once-daily basal or premix insulin therapy can be converted unit-to-unit to once- or twice-daily Ryzodeg at the same total insulin dose as the patient's previous total daily insulin dose.
Croatian: Bolesnici koji prelaze s inzulinskog liječenja bazalnim inzulinom ili predmiješanim inzulinom više nego jednom dnevno mogu biti prebačeni na liječenje lijekom Ryzodeg jednom ili dva puta dnevno, po načelu jedinica za jedinicu, u istoj ukupnoj dozi inzulina koja odgovara ukupnoj dnevnoj dozi inzulina kojeg je bolesnik prethodno koristio.
English: Ryzodeg can be used in adolescents and children from the age of 2 years with diabetes mellitus.
Croatian: Ryzodeg se može primjenjivati u adolescenata i djece sa šećernom bolešću od navršene 2 godine života.
English: The half-life of the basal component (insulin degludec) at steady state is 25 hours independent of dose.
Croatian: Poluvijek bazalnog sastojka (degludek inzulina) u stanju dinamičke ravnoteže iznosi 25 sati,
English: • how much Ryzodeg you will need each day and at which meal(s) • when to check your blood sugar level and if you need a higher or lower dose.
Croatian: • kada provjeriti razinu šećera u krvi i je li Vam potrebna veća ili manja doza.
English: If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use the pen without help.
Croatian: Ako ste slijepi ili slabo vidite i ne možete pročitati brojčanik doze na brizgalici, nemojte koristiti brizgalicu bez pomoći.
English: Fasting Plasma Glucose (FPG) (mmol/L)
Croatian: Glukoza u plazmi natašte (GUP natašte) (mmol/l)
English: Ryzodeg is used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Croatian: Ryzodeg se koristi za liječenje šećerne bolesti u odraslih, adolescenata i djece od navršene 2 godine života.
English: Treatment of diabetes mellitus in adults, adolescents and children from the age of 2 years.
Croatian: Liječenje šećerne bolesti u odraslih, adolescenata i djece u dobi od navršene 2 godine života.
English: Ryzodeg o.d.or b.i.d demonstrated similar glycaemic control (HbA1c) compared to IGlar o.d. plus IAsp 13 times daily after 38 weeks (the estimated mean reductions are -1.17% vs -1.26%).
Croatian: Nakon 38 tjedana, Ryzodeg j.d. ili d.d. ostvario je sličnu regulaciju glikemije (HbA1c) kao i IGlar j.d. plus IAsp 1-3 puta dnevno (procijenjene srednje vrijednosti smanjenja su -1,17% naspram -1,26%).
English: This medicinal product is a soluble insulin product consisting of the basal insulin degludec and the rapid-acting prandial insulin aspart.
Croatian: Ovaj lijek je inzulinski pripravak u obliku otopine koji sadrži bazalni degludek inzulin i prandijalni brzodjelujući aspart inzulin.
English: demonstrated similar glycaemic control (HbA1c) compared with BIAsp 30 b.i.d.
Croatian: Ryzodeg d.d. pokazuje sličnu regulaciju glikemije (HbA1c) u usporedbi s BIAsp 30 d.d. u bolesnika sa šećernom bolešću tipa
English: Ryzodeg o.d. demonstrated similar glycaemic control (HbA1c) compared to IGlar o.d. plus IAsp o.d. after 26 weeks (the estimated mean reductions are -1.01% vs -1.09%).
Croatian: Ryzodeg j.d. je nakon 26 tjedana ostvario sličnu regulaciju glikemije (HbA1c) kao i IGlar j.d. plus IAsp j.d (procijenjene srednje vrijednosti smanjenja su -1,01% naspram -1,09%).
English: Steady-state serum concentration of the basal component (insulin degludec) is reached after 2-3 days of daily Ryzodeg administration.
Croatian: Stanje dinamičke ravnoteže u serumu bazalnog sastojka (degludek inzulina) postiže se nakon 2-3 dana svakodnevne primjene lijeka
English: • Check the name and strength on the label of your pen, to make sure that it contains Ryzodeg 100 units/mL.
Croatian: • Provjerite naziv i jačinu na naljepnici Vaše brizgalice kako biste bili sigurni da sadrži Ryzodeg 100 jedinica/ml.
English: Difference: -1.06 [-1.43;-0.70]
Croatian: Razlika: -1,06 [-1,43; -0,70]
English: Ratio: 1.00 [0.76;1.32]
Croatian: Omjer: 1,00 [0,76; 1,32]
English: Patients switching from once-daily basal or premix insulin therapy can be converted unit-to-unit to once- or twice-daily Ryzodeg at the same total insulin dose as the patient's previous total daily insulin dose.
Croatian: Bolesnici koji prelaze s inzulinskog liječenja bazalnim inzulinom ili predmiješanim inzulinom jednom dnevno mogu biti prebačeni na liječenje lijekom Ryzodeg jednom ili dva puta dnevno, po načelu jedinica za jedinicu, u istoj ukupnoj dozi inzulina koja odgovara ukupnoj dnevnoj dozi inzulina kojeg je bolesnik prethodno koristio.
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen 3 mL solution in a cartridge (type 1 glass) with a plunger (halobutyl) and a laminate rubber sheet (halobutyl/polyisoprene) contained in a multidose disposable pre-filled pen made of polypropylene.
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici 3 ml otopine u ulošku (staklo tipa 1) s klipom (halobutil) i pokrovom od laminirane gume (halobutil/poliizopren) nalazi se u jednokratnoj, višedoznoj napunjenoj brizgalici od polipropilena.
English: The frequency, type and severity of adverse reactions in the paediatric population do not indicate differences to the experience in the general diabetes population with the exception of a signal of higher occurrence of severe hypoglycaemia compared to a basalbolus regimen in the paediatric population, particularly in children 2 to 5 years old (see section 4.2, 4.4 and 5.1).
Croatian: Učestalost, vrsta i težina nuspojava u pedijatrijskoj populaciji ne upućuju na razlike u odnosu na iskustvo u općoj populaciji bolesnika sa šećernom bolešću, osim signala češće pojave teške hipoglikemije u odnosu na bazal-bolus režim u pedijatrijskoj populaciji,
English: Ratio: 0.68 [0.52;0.89]
Croatian: Omjer: 0,68 [0,52; 0,89]
English: Ratio: 0.29 [0.13;0.65]
Croatian: Omjer: 0,29 [0,13; 0,65]
English: Ryzodeg 100 units/mL solution for injection in cartridge Ryzodeg comes in a cartridge (Penfill) designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist injection needles.
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku Ryzodeg dolazi u obliku uloška (Penfill) namijenjenog uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama za injekciju NovoFine ili NovoTwist.
English: Use only clear, colourless solution Single patient use only
Croatian: Upotrijebiti samo bistru, bezbojnu otopinu.
English: Ratio: 0.80 [0.49;1.30]
Croatian: Omjer: 0,80 [0,49; 1,30]
English: Instructions on how to use Ryzodeg 100 units/mL solution for injection in pre-filled pen (FlexTouch)
Croatian: Upute za uporabu Ryzodeg 100 jedinica/ml otopine za injekciju u napunjenoj brizgalici (FlexTouch)
English: Both treatments improved glycaemic control with an estimated mean reduction with Ryzodeg (-1.23%) against IDeg plus IAsp (-1.42%) for the primary endpoint of change from baseline in HbA1c at 26 weeks.
Croatian: Oba su liječenja poboljšala regulaciju glikemije, ali procijenjena srednja vrijednost smanjenja uz Ryzodeg (-1,23%) nije postigla unaprijed specificiranu granicu neinferiornosti od 0,4% [0,18 (-0,04; 0,41)] u odnosu na IDeg plus IAsp (-1.42%) za primarnu mjeru ishoda, koja je bila promjena vrijednosti HbA1c od početka ispitivanja do 26. tjedna.
English: Common (may affect up to 1 in 10 people)
Croatian: Druge nuspojave uključuju: Često (mogu se javiti u do 1 na 10 osoba)
English: Table 3 Result of a 26-weeks' trial in type 1 diabetes mellitus with Ryzodeg given once daily
Croatian: Tablica 3 Rezultati ispitivanja u trajanju od 26 tjedana kod šećerne bolesti tipa 1 uz Ryzodeg primijenjen jednom dnevno
English: Ryzodeg is presented as a clear and colourless solution for injection in pre-filled pen (300 units per 3 mL).
Croatian: Ryzodeg dolazi u obliku bistre i bezbojne otopine za injekciju u napunjenoj brizgalici (300 jedinica u 3 ml).
English: In one trial of patients with type 2 diabetes mellitus treated with basal insulin, in need of treatment intensification with mealtime insulin, Ryzodeg o.d. was compared to IGlar o.d. plus IAsp o.d. over 26 weeks.
Croatian: U jednom ispitivanju provedenom u bolesnika sa šećernom bolešću tipa 2 koji su se liječili bazalnim inzulinom i kojima je bilo potrebno intenziviranje liječenja inzulinom koji se primjenjuje uz obrok, Ryzodeg j.d. uspoređivao se s IGlar j.d. plus IAsp j.d. tijekom 26 tjedana.
English: Ratio: 0.27 [0.18;0.41]
Croatian: Omjer: 0,27 [0,18; 0,41]
English: The following substances may reduce the insulin requirement Oral antidiabetic medicinal products, GLP-1 receptor agonists, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulfonamides.
Croatian: beta-blokatori, inhibitori angiotenzin konvertirajućeg enzima (ACE inhibitori), salicilati, anabolički steroidi i sulfonamidi.
English: Ryzodeg is presented as a clear and colourless solution for injection in a cartridge (300 units per 3 mL).
Croatian: Ryzodeg dolazi u obliku bistre i bezbojne otopine za injekciju u ulošku (300 jedinica u 3 ml).
English: Ratio: 0.91 [0.76;1.09]
Croatian: Omjer: 0,91 [0,76; 1,09]
English: EU/1/12/806/008
Croatian: EU/1/12/806/007 EU/1/12/806/008
English: Make sure the dose counter shows 2.
Croatian: Provjerite da brojčanik doze pokazuje
English: Avoidance of accidental mix-ups
Croatian: Izbjegavanje slučajne zamjene
English: Ratio: 0.67 [0.43;1.06]
Croatian: Omjer: 0,67 [0,43; 1,06]
English: • acetylsalicylic acid (and other salicylates), for pain and mild fever
Croatian: • acetilsalicilatnu kiselinu (i druge salicilate), za bol i blagu vrućicu • inhibitore monoaminooksidaze (MAO inhibitore), za depresiju
English: Difference: 0.05 [-0.10;0.20]
Croatian: Razlika: 0,05 [-0,10; 0,20]
English: Ratio: 0.63 [0.49;0.81]
Croatian: Omjer: 0,63 [0,49; 0,81]
English: Package leaflet: Information for the patient Ryzodeg 100 units/mL solution for injection in pre-filled pen
Croatian: Uputa o lijeku: Informacije za bolesnika Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
English: Ryzodeg has a rapid onset of action occurring soon after injection providing mealtime coverage while the basal component has a flat and stable action profile providing continuous coverage of the basal insulin requirements.
Croatian: dok bazalni sastojak ima ravnomjeran i stabilan profil djelovanja, što omogućuje neprekidno pokrivanje potreba za bazalnim inzulinom.
English: • The active substances are insulin degludec and insulin aspart.
Croatian: • Djelatne tvari su degludek inzulin i aspart inzulin.
English: Gender There is no gender difference in the pharmacokinetic properties of Ryzodeg.
Croatian: Ne postoji razlika u farmakokinetičkim svojstvima lijeka Ryzodeg ovisno o spolu.
English: Time since injection (hours) Treatment
Croatian: Vrijeme proteklo od injiciranja (sati) Liječenje IDegAsp 0,8 U/kg
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen Ryzodeg 100 units/mL solution for injection in cartridge
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku
English: Difference: -0.05 [-0.18;0.08]
Croatian: Razlika: -0,05 [-0,18; 0,08]
English: There is no clinical experience with the use of this medicinal product in children below the age of 2 years.
Croatian: Pedijatrijska populacija Nema kliničkog iskustva s primjenom ovog lijeka u djece mlađe od 2 godine.
English: End of trial Mean change
Croatian: Na početku ispitivanja, vrijednost
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen One pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 mL solution.
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 300 jedinica degludek inzulina/aspart inzulina u 3 ml otopine.
English: Ryzodeg o.d. plus insulin aspart (IAsp) was also compared to o.d. or b.i.d.
Croatian: šećernoj bolesti tipa 1 (Tablica 3) Ryzodeg j.d. zajedno s aspart inzulinom (IAsp) uspoređivao se i s detemir inzulinom (IDet) j.d. ili d.d. plus IAsp.
English: • you start being sick (vomiting)
Croatian: • odjednom se osjećate loše i znojite se • povraćanje
English: Table 2 Result from two 26-weeks' trials in type 2 diabetes mellitus with Ryzodeg given twice daily
Croatian: Tablica 2 Rezultati dvaju ispitivanja u trajanju od 26 tjedana kod šećerne bolesti tipa 2 uz primjenu lijeka Ryzodeg dvaput dnevno
English: Stop using Ryzodeg and see a doctor straight away if the reactions become serious.
Croatian: Ryzodeg, prestanite primjenjivati ovaj lijek i odmah posjetite liječnika.
English: dosing in the Ryzodeg arm and additional IAsp doses could be administered at other meals (up to 3 times daily) in the IGlar arm.
Croatian: Nakon 26 tjedana doza lijeka Ryzodeg se u skupini liječenoj tim lijekom mogla podijeliti na dvije zasebne doze (d.d.), dok su se u skupini koja je primala IGlar uz ostale obroke mogle primjenjivati dodatne doze IAsp (do 3 puta dnevno).
English: Keep the cartridges in the outer carton in order to protect from light.
Croatian: Uloške čuvati u vanjskoj kutiji radi zaštite od svjetlosti.
English: Can be stored in a refrigerator (2°C - 8°C).
Croatian: Može se čuvati u hladnjaku (2°C-8°C).
English: Prandial Blood glucose Increment 90 minutes after dosing meal (Plasma) (mmol/L)
Croatian: Razlika: 0,33 [-0,11; 0,77] Povećanje prandijalne glukoze u krvi (plazmi) 90 minuta nakon doziranja uz obrok (mmol/l)
English: Fatty tissue under the skin may shrink (lipoatrophy) or get thicker (lipohypertrophy).
Croatian: Potkožno masno tkivo može se smanjiti (lipoatrofija) ili povećati (lipohipertrofija).
English: What Ryzodeg is and what it is used for What you need to know before you use Ryzodeg How to use Ryzodeg
Croatian: Što morate znati prije nego počnete primjenjivati Ryzodeg
English: Ryzodeg 100 units/mL solution for injection in cartridge One cartridge contains 300 units of insulin degludec/insulin aspart in 3 mL solution.
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku Jedan uložak sadrži 300 jedinica degludek inzulina/aspart inzulina u 3 ml otopine.
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen Ryzodeg comes in a pre-filled pen (FlexTouch) designed to be used with NovoFine or NovoTwist injection needles.
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Ryzodeg dolazi u obliku napunjene brizgalice (FlexTouch) namijenjene uporabi s iglama za injekciju
English: Ryzodeg 100 units/mL solution for injection in cartridge 3 mL solution in a cartridge (type 1 glass) with a plunger (halobutyl) and a laminate rubber sheet (halobutyl/polyisoprene) in a carton.
Croatian: 3 ml otopine u ulošku (staklo tipa 1) s klipom (halobutil) i pokrovom od laminirane gume (halobutil/poliizopren), u kutiji.
English: Table 1 Result from two 26-weeks' trials in type 2 diabetes mellitus with Ryzodeg given once daily
Croatian: Tablica 1 Rezultati dvaju ispitivanja u trajanju od 26 tjedana kod šećerne bolesti tipa 2 uz primjenu lijeka Ryzodeg jednom dnevno
English: As with other basal insulin products or insulin products with a basal component, the prolonged effect of Ryzodeg may delay recovery from hypoglycaemia.
Croatian: Kao i kod drugih bazalnih inzulinskih pripravaka ili inzulinskih pripravaka s bazalnim sastojkom,
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen Solution for injection (FlexTouch).
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Otopina za injekciju (FlexTouch).
English: • Test your blood sugar level.
Croatian: ‘Preniska razina šećera u krvi'.
English: See your delivery system manual for further instructions.
Croatian: Za dodatne informacije pročitajte upute za uporabu Vašeg pomagala za primjenu inzulina.
English: Each cartridge contains 300 units of insulin degludec/insulin aspart in 3 mL solution.
Croatian: Jedan uložak sadrži 300 jedinica degludek inzulina/aspart inzulina u 3 ml otopine.
English: • Check the name and strength on the label of the pen to make sure it is Ryzodeg 100 units/mL.
Croatian: • Provjerite naziv i jačinu na naljepnici brizgalice kako biste bili sigurni da je to Ryzodeg 100
English: Ryzodeg (o.d.)1 Insulin naïve
Croatian: (d.d.)1 Koriste inzulin
English: Hypersensitivity Urticaria
Croatian: Preosjetljivost Urtikarija
English: Ryzodeg 100 units/mL solution for injection in cartridge After first opening or carried as a spare, the medicinal product may be stored for a maximum of 4 weeks.
Croatian: Nakon prvog otvaranja ili ako se nosi kao rezervni, lijek se može čuvati najviše 4 tjedna.
English: 1 mL solution contains 100 units insulin degludec/insulin aspart* in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart).
Croatian: 1 ml otopine sadrži 100 jedinica degludek inzulina/aspart inzulina* u omjeru 70/30 (što odgovara 2,56 mg degludek inzulina i 1,05 mg aspart inzulina).
English: Ryzodeg 100 units/mL solution for injection 70% insulin degludec / 30% insulin aspart FlexTouch
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju 70% degludek inzulina / 30% aspart inzulina FlexTouch
English: IGlar (o.d.)2 Insulin users
Croatian: (d.d.)2 Koriste inzulin
English: Ryzodeg 100 units/mL solution for injection in cartridge Solution for injection (Penfill).
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju u ulošku Otopina za injekciju (Penfill).
English: Each pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 mL solution.
Croatian: Jedna napunjena brizgalica sadrži 300 jedinica degludek inzulina/aspart inzulina u 3 ml otopine.
English: Ryzodeg 100 units/mL solution for injection 70% insulin degludec / 30% insulin aspart Penfill
Croatian: Ryzodeg 100 jedinica/ml otopina za injekciju 70% degludek inzulina / 30% aspart inzulina Penfill
English: with IDeg o.d. plus IAsp 2-4 times daily) in type 2 diabetes mellitus.
Croatian: IDegAsp d.d. uspoređivao s IDeg j.d. plus IAsp 2-4 puta dnevno) neinferiornost nije potvrđena.
English: Each mL of solution contains 100 units insulin degludec/insulin aspart in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart).
Croatian: Jedan ml otopine sadrži 100 jedinica degludek inzulina/aspart inzulina u omjeru 70/30 (što odgovara 2,56 mg degludek inzulina i 1,05 mg aspart inzulina).
English: IDegAsp 0.8 U/kg
Croatian: 4.8 Nuspojave